Table 1.

Demographic, clinical and laboratory data of patients (ST=on statin therapy vs. NST=not on statin therapy)

N = 501	Total cohort	Min–Max	ST (n = 51)	NST (n = 450)	p value
Age, years	72 ± 17	19–99	76 ± 10	71 ± 17	0.030
CCI, points	2.0  ±  2.3	0–12	2.8 ± 2.4	2.0 ± 1.3	0.010
Length of stay, days	19 ± 15	1–92	16 ± 11	20 ± 15	0.120
MEWS score, points	1.8 ± 1.2	0–9	1.7 ± 0.96	1.8 ± 1.2	0.520
SBP, mmHg	129 ± 21	80–190	135 ± 23	129 ± 21	0.050
DBP, mmHg	74 ± 12	40–120	74 ± 12	73 ± 12	0.650
HR, bpm	85 ± 17	43–159	83 ± 15	86 ± 17	0.270
RR, apm	22 ± 6	12–59	22 ± 7	22 ± 6	0.880
P/F ratio	284±111	68–971	288±93	284±113	0.850
WBC, n/mmc	8354 ± 6838	1720–101,730	6865 ± 2705	8524 ± 7143	0.310
Lymphocytes, n/mmc	1340 ± 2647	129-46,540	1041 ± 501	1374 ± 2787	0.330
CRP, mg/dl	8.3 ± 8.6	0–65	6.4 ± 5.6	8.5 ± 8.9	0.110
Procalcitonin, (ng/ml)	1.6 ± 6.9	0–100	0.9±2.8	1.7 ± 7.4	0.010
Creatinine, mg/dl	1.37 ± 1.66	0.1–19.6	1.14 ± 0.60	1.4 ± 1.7	0.760
eGFR, ml/min	67 ± 31	0.5–173.6	64 ± 23	67 ± 32	0.520
LDH, mg/dl	305 ± 164	59–1741	301 ± 98	305 ± 171	0.280
BNP, pg/ml	244 ± 528	0–5000	181 ± 198	255 ± 566	0.370
Fibrinogen, mg/dl	536 ± 182	113–1277	534 ± 173	536 ± 183	0.950
D-Dimer, ng/ml	2.6 ± 5.1	0–35	2.5 ± 5.0	2.6 ± 5.2	0.860
Isoamylase, U/l	47 ± 52	1–571	38 ± 40	48 ± 54	0.330
ALT, U/l	36 ± 68	3–1120	24 ± 15	38 ± 72	0.300
CPK, U/l	283 ± 1124	10–16,333	336 ± 463	275 ± 1191	0.003
Ferritin, ng/ml	618–877	5–6399	711 ± 1361	608 ± 807	0.890
Troponin, ng/ml	70 ± 293	0–3704	84 ± 248	68 ± 302	0.060

All data are expressed as mean ± SD

Bold p values < 0.05 are considered statistically significant

CCI Charlson Comorbidity Index, MEWS Modified Early Warning Score, SBP Sistolic blood pressure, DBP diastolic blood pressure, HR heart rate, RR respiratory rate, WBC white blood cells, CRP C reactive protein, eGFR estimated Glomerular filtration rate, LDH lactic dehydrogenase, BNP brain natriuretic peptide, ALT alanine transferase, CPK creatinine phosphokinase